RecruitingNot applicableNCT03538912

Early Discontinuation of Empirical Antifungal Therapy and Biomarkers

Studying Invasive candidiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Lille
Principal Investigator
Anahita Rouze, MD
University Hospital, Lille
Intervention
Biomarker strategy(other)
Enrollment
194 target
Eligibility
18 years · All sexes
Timeline
2018 – 2025

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03538912 on ClinicalTrials.gov

Other trials for Invasive candidiasis

Additional recruiting or active studies for the same condition.

See all trials for Invasive candidiasis →

← Back to all trials